177 related articles for article (PubMed ID: 24825343)
1. Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.
Guéry B; Alberti C; Servais A; Harrami E; Bererhi L; Zins B; Touam M; Joly D
PLoS One; 2014; 9(5):e97187. PubMed ID: 24825343
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
Trials; 2013 Jun; 14():163. PubMed ID: 23725299
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
5. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
[TBL] [Abstract][Full Text] [Related]
7. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.
Laville M; Dorval M; Fort Ros J; Fay R; Cridlig J; Nortier JL; Juillard L; Dębska-Ślizień A; Fernández Lorente L; Thibaudin D; Franssen C; Schulz M; Moureau F; Loughraieb N; Rossignol P
Kidney Int; 2014 Dec; 86(6):1260-7. PubMed ID: 25007166
[TBL] [Abstract][Full Text] [Related]
8. Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of on-line predilution hemodiafiltration with conventional hemodialysis.
Brunot V; Serre JE; Mourad G; Klouche K; Pernin V
Hemodial Int; 2018 Oct; 22(4):463-473. PubMed ID: 29745004
[TBL] [Abstract][Full Text] [Related]
9. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
[TBL] [Abstract][Full Text] [Related]
10. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
[TBL] [Abstract][Full Text] [Related]
11. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
12. Expanded hemodialysis: Is anticoagulation of the dialysis circuit different from online hemodiafiltration and high-flux hemodialysis?
Santos A; Macías N; Vega A; Abad S; Linares T; Aragoncillo I; Cruzado L; Pascual C; Goicoechea M; López-Gómez JM
Ther Apher Dial; 2022 Feb; 26(1):147-153. PubMed ID: 33890717
[TBL] [Abstract][Full Text] [Related]
13. Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.
Janssens FV; Meijers B; François K
Semin Nephrol; 2023 Nov; 43(6):151483. PubMed ID: 38220473
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis without anticoagulation: Less clotting in conventional hemodialysis than in predilution hemodiafiltration.
Krummel T; Cellot E; Thiery A; De Geyer G; Keller N; Hannedouche T
Hemodial Int; 2019 Oct; 23(4):426-432. PubMed ID: 31380605
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding.
Schwab SJ; Onorato JJ; Sharar LR; Dennis PA
Am J Med; 1987 Sep; 83(3):405-10. PubMed ID: 3310620
[TBL] [Abstract][Full Text] [Related]
16. Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.
Vanommeslaeghe F; De Somer F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
Artif Organs; 2019 Aug; 43(8):756-763. PubMed ID: 30820962
[TBL] [Abstract][Full Text] [Related]
17. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
18. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
Su T; Jin Q; Liu Z
BMC Nephrol; 2017 Jun; 18(1):208. PubMed ID: 28666474
[TBL] [Abstract][Full Text] [Related]
19. Low dose of argatroban saline flushes anticoagulation in hemodialysis patients with high risk of bleeding.
Yixiong Z; Jianping N; Yanchao L; Siyuan D
Clin Appl Thromb Hemost; 2010 Aug; 16(4):440-5. PubMed ID: 19833621
[TBL] [Abstract][Full Text] [Related]
20. Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.
Lin T; Song L; Huang R; Huang Y; Tang S; Lin Q; Zhang Y; Wu X; Liang H; Wu Y; Chen Y; Liang H; Ma J; Feng Z; Li Z; Xu L; Fu X; Ye Z; Liu S; Liang X
BMC Nephrol; 2019 Dec; 20(1):472. PubMed ID: 31856749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]